Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Fourmy

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 24, 2002
c-Jun NH(2)-terminal kinase pathway in growth-promoting effect of the G protein-coupled receptor cholecystokinin B receptor: a protein kinase C/Src-dependent-mechanismStephanie Dehez, Christiane Bierkamp, Aline Kowalski-Chauvel, et al.
Journal of Medicinal Chemistry|January 7, 2005
Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptorElodie Archer-Lahlou, Irina Tikhonova, Chantal Escrieut, et al.
British Journal of Pharmacology|February 24, 2006
Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptorGéraldine Ibarz, Catherine Oiry, Eric Carnazzi, et al.
Molecular Pharmacology|December 10, 2008
Evidence for a direct and functional interaction between the regulators of G protein signaling-2 and phosphorylated C terminus of cholecystokinin-2 receptorIngrid Langer, Irina G Tikhonova, Cyril Boulègue, et al.
Journal of Medicinal Chemistry|October 1, 2004
5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: reversal of CCK1 receptor subtype selectivity toward CCK2 receptorsPilar Muñoz-Ruiz, M Teresa García-López, Edurne Cenarruzabeitia, et al.
Pharmacogenetics|January 5, 2002
Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patientsSophie Marchal-Victorion, Nathalie Vionnet, Chantal Escrieut, et al.
Molecular Pharmacology|April 16, 2003
Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studiesCéline Galés, Marc Poirot, Julien Taillefer, et al.
Journal of Molecular Modeling|February 21, 2008
Exploring the binding pocket for pyridopyrimidine ligands at the CCK1 receptor by molecular dockingAmel Toumi-Maouche, Boubekeur Maouche, Safia Taïri-Kellou, et al.
Cancer Research|April 5, 2005
Signaling pathways associated with colonic mucosa hyperproliferation in mice overexpressing gastrin precursorsAudrey Ferrand, Claudine Bertrand, Ghislaine Portolan, et al.
The Journal of Biological Chemistry|January 11, 2005
A novel mechanism for JAK2 activation by a G protein-coupled receptor, the CCK2R: implication of this signaling pathway in pancreatic tumor modelsAudrey Ferrand, Aline Kowalski-Chauvel, Claudine Bertrand, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 24, 2002
c-Jun NH(2)-terminal kinase pathway in growth-promoting effect of the G protein-coupled receptor cholecystokinin B receptor: a protein kinase C/Src-dependent-mechanismStephanie Dehez, Christiane Bierkamp, Aline Kowalski-Chauvel, et al.
Journal of Medicinal Chemistry|January 7, 2005
Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptorElodie Archer-Lahlou, Irina Tikhonova, Chantal Escrieut, et al.
British Journal of Pharmacology|February 24, 2006
Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptorGéraldine Ibarz, Catherine Oiry, Eric Carnazzi, et al.
Molecular Pharmacology|December 10, 2008
Evidence for a direct and functional interaction between the regulators of G protein signaling-2 and phosphorylated C terminus of cholecystokinin-2 receptorIngrid Langer, Irina G Tikhonova, Cyril Boulègue, et al.
Journal of Medicinal Chemistry|October 1, 2004
5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: reversal of CCK1 receptor subtype selectivity toward CCK2 receptorsPilar Muñoz-Ruiz, M Teresa García-López, Edurne Cenarruzabeitia, et al.
Pharmacogenetics|January 5, 2002
Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patientsSophie Marchal-Victorion, Nathalie Vionnet, Chantal Escrieut, et al.
Molecular Pharmacology|April 16, 2003
Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studiesCéline Galés, Marc Poirot, Julien Taillefer, et al.
Journal of Molecular Modeling|February 21, 2008
Exploring the binding pocket for pyridopyrimidine ligands at the CCK1 receptor by molecular dockingAmel Toumi-Maouche, Boubekeur Maouche, Safia Taïri-Kellou, et al.
Cancer Research|April 5, 2005
Signaling pathways associated with colonic mucosa hyperproliferation in mice overexpressing gastrin precursorsAudrey Ferrand, Claudine Bertrand, Ghislaine Portolan, et al.
The Journal of Biological Chemistry|January 11, 2005
A novel mechanism for JAK2 activation by a G protein-coupled receptor, the CCK2R: implication of this signaling pathway in pancreatic tumor modelsAudrey Ferrand, Aline Kowalski-Chauvel, Claudine Bertrand, et al.
Pageof 8